Related Experiment Videos
Nomenclature for human CYP2D6 alleles
A K Daly1, J Brockmöller, F Broly
1Pharmacogenetics Research Unit, University of Newcastle upon Tyne, Medical School, UK.
Pharmacogenetics
|June 1, 1996
Summary
A new standardized nomenclature for CYP2D6 alleles is proposed to replace the current arbitrary system. This system uses gene names, asterisks, and alphanumeric codes to clearly identify specific genetic variations and mutations.
Area of Science:
- Pharmacogenomics
- Human Genetics
- Molecular Biology
Background:
- The current nomenclature for cytochrome P450 2D6 (CYP2D6) alleles is arbitrary and lacks standardization.
- This inconsistency hinders clear communication and accurate data interpretation in genetic research and clinical practice.
Purpose of the Study:
- To propose a standardized nomenclature for CYP2D6 alleles.
- To align with international human gene nomenclature guidelines.
- To provide clear criteria for classifying distinct alleles and protein variants.
Main Methods:
- The study describes a proposed nomenclature system based on recommendations for human genome nomenclature.
- Alleles are designated as CYP2D6* followed by alphanumeric combinations.
- Numbers indicate key mutations, and letters denote additional mutations.
Main Results:
- A systematic approach for designating CYP2D6 alleles is presented.
- The proposed system ensures distinct identification for each allele.
- Criteria for allele classification and protein nomenclature are defined.
Conclusions:
- The proposed standardized nomenclature offers a clear and systematic method for identifying CYP2D6 alleles.
- This system facilitates better communication and consistency in pharmacogenomics and related fields.
- Adoption of this nomenclature will improve the accuracy of genetic variant interpretation.